Although aberrant DNA methylation is considered to be one of the key ways by which tumor-suppressor and DNA-repair genes are silenced during tumor initiation and progression, the mechanisms underlying DNA methylation alterations in cancer remain unclear. Here we show that prostaglandin E2 (PGE2) silences certain tumor-suppressor and DNA-repair genes through DNA methylation to promote tumor growth. These findings uncover a previously unrecognized role for PGE2 in the promotion of tumor progression.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Wang, D. & DuBois, R.N. Oncogene 29, 781–788 (2010).
Wang, D. & DuBois, R.N. Nat. Rev. Cancer 10, 181–193 (2010).
Baba, Y. et al. Cancer Epidemiol. Biomarkers Prev. 19, 822–831 (2010).
Slattery, M.L. et al. Int. J. Cancer 120, 656–663 (2007).
Kim, M.S., Lee, J. & Sidransky, D. Cancer Metastasis Rev. 29, 181–206 (2010).
Kim, Y.H. et al. Genes Chromosom. Cancer 45, 781–789 (2006).
Wang, D. et al. Cancer Res. 68, 6468–6476 (2008).
De Marzo, A.M. et al. Cancer Res. 59, 3855–3860 (1999).
Schmidt, W.M. et al. Mol. Carcinog. 46, 766–772 (2007).
Nosho, K. et al. Clin. Cancer Res. 15, 3663–3671 (2009).
Ibrahim, A.E. et al. Gut 60, 499–508 (2011).
Kanai, Y., Ushijima, S., Kondo, Y., Nakanishi, Y. & Hirohashi, S. Int. J. Cancer 91, 205–212 (2001).
Steine, E.J. et al. J. Clin. Invest. 121, 1748–1752 (2011).
Lin, H. et al. Mol. Cell Biol. 26, 2976–2983 (2006).
Linhart, H.G. et al. Genes Dev. 21, 3110–3122 (2007).
Shteper, P.J. et al. Oncogene 22, 7737–7749 (2003).
Pakneshan, P., Szyf, M., Farias-Eisner, R. & Rabbani, S.A. J. Biol. Chem. 279, 31735–31744 (2004).
Hamm, C.A. et al. PLoS ONE 4, e8340 (2009).
Ogino, S. et al. J. Natl. Cancer Inst. 100, 1734–1738 (2008).
Ahn, J.B. et al. Cancer 117, 1847–1854 (2011).
We thank D. Menter and P. Yang for their suggestions and help in the measurement of PGE2. This work is supported, in part, by the US National Institutes of Health MERIT award grants R37 DK47297, RO1 DK62112, NCI P01 CA77839 and CPRIT RP100960. We also thank the National Colorectal Cancer Research Alliance (NCCRA) for its generous support (R.N.D.) and a cancer prevention fellowship (D.X.) supported by the National Cancer Institute grant R25T CA57730 (principal investigator, S. Chang).
The authors declare no competing financial interests.
About this article
Cite this article
Xia, D., Wang, D., Kim, SH. et al. Prostaglandin E2 promotes intestinal tumor growth via DNA methylation. Nat Med 18, 224–226 (2012). https://doi.org/10.1038/nm.2608
Nature Reviews Clinical Oncology (2021)
Signal Transduction and Targeted Therapy (2021)
Pattern of organ remodeling in chronic non-communicable diseases is due to endogenous regulations and falls under the category of Kauffman’s self-organization: A case of arterial neointimal pathology
Medical Hypotheses (2020)
Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis
Cancer Medicine (2020)
Journal of Molecular Medicine (2020)